Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Dropbox (DBX)

Dropbox names Ross Tennenbaum CFO, succeeding Tim Regan effective December 16, 2025

Neutral Impact 4 of 5 leadership Written later

Dropbox said CFO Timothy Regan will resign effective December 16, 2025, and Ross Tennenbaum, formerly President at Avalara, will succeed him as Chief Financial Officer on the same date. The company also said its fourth quarter and fiscal 2025 results are expected to be in line with or above previously provided guidance ranges, which matters to shareholders because it is the company's first update on those results in the filing.

Key points

  • Timothy Regan resigns as CFO effective December 16, 2025, and remains a non-executive employee through March 15, 2026, with a one-time $250,000 advisory fee in December 2025
  • Ross Tennenbaum, 47, appointed CFO effective December 16, 2025, with a $550,000 base salary and a $23,250,000 RSU grant
  • Dropbox expects fourth quarter and fiscal 2025 results in line with or above guidance ranges given November 6, 2025

The filing

CompanyDropbox (DBX)
Form8-K, current report
Filed with the SECDec 10, 2025, 9:02 AM ET
Accession number0001467623-25-000131

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 10, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.